In the Spotlight

Catherine Jutzeler was awarded in 2020 both an SNSF Spark Grant and an SNSF Ambizione Grant to set up her own research group. Only one year later, she has been appointed as a Tenure-Track Assistant Professor […]

Bacteria, which are particularly common in multiple sclerosis (MS) patients, could be the trigger for the inflammatory reactions in the brain and spinal cord. Endogenous proteins of the brain and protein building blocks of these […]

Walking is a central part of independent living. Neurological causes, such as stroke or Parkinson’s disease, can substantially impair gait and mobility. This affects our quality of life, as many studies have shown. In precision […]

A violent assault or a car accident – traumatic events in the past could affect your present and future health. They can trigger emotional and even physical reactions that make you more prone to a […]

When an ischemic stroke occurs, blood flow is cut off to parts of the brain. Self-healing mechanisms, such as reorganization of the brain exist and are initiated immediately. The researchers behind the UZH Clinical Research […]

The new University Research Priority Program (URPP) “Adaptive Brain Circuits in Development and Learning” aims at better understanding the mechanisms underlying brain development and learning as well as the causes of learning deficits. The URPP […]

Nicolas Langer of the Department of Psychology at UZH and colleagues are developing a web application for the automated interpretation of the Rey-Osterrieth complex figure, a widely used neuropsychological test. The tool might save a single […]

Chronic pain is one of the most common medical conditions and has a big impact on the quality of a patient’s life. Yet, it is often difficult to treat. The Clinical Research Priority Program (CRPP) […]

The use of immunotherapy to attack tumors is a promising new approach to cancer treatment. The Clinical Research Priority Program (CRPP) ImmunoCure intends to develop immunotherapeutic strategies for brain tumors. We talked with Patrick Roth […]

Multiple sclerosis (MS) is a highly heterogeneous disease. Patients respond differently to medications and have disease prognoses that vary greatly. The new Clinical Research Priority Program (CRPP) PrecisionMS looks at how therapies can be adapted […]